Literature DB >> 15372260

Intravenous immunoglobulins, pregnancy and multiple sclerosis.

Christian Confavreux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15372260     DOI： 10.1007/s00415-004-0496-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  3 in total

1.  Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.

Authors:  F Fazekas; F Deisenhammer; S Strasser-Fuchs; G Nahler; B Mamoli
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

2.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

3.  Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis.

Authors:  Anat Achiron; Irena Kishner; Mark Dolev; Yael Stern; Mordechai Dulitzky; Eyal Schiff; Reuven Achiron
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849
  3 in total
  3 in total

Review 1.  Multiple sclerosis and pregnancy in the 'treatment era'.

Authors:  Sandra Vukusic; Romain Marignier
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

Review 2.  [Pregnancy and immunomodulatory therapy in multiple sclerosis patients].

Authors:  L A Hoffmann; T Kümpfel; I Heer; R Hohlfeld
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.